|
|
||||||||
J Thorac Cardiovasc Surg 2007;133:934-941
© 2007 The American Association for Thoracic Surgery
Cardiopulmonary Support and Physiology |
a Department of Neurosurgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
d Department of Medical Research, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
b Department of Biological Sciences, National Sun-Yat Sen University, Kaohsiung, Taiwan
c Department of Neurology, Chang-Gung Memorial Hospital, Kaohsiung, Taiwan.
Received for publication August 18, 2006; revisions received October 12, 2006; accepted for publication November 3, 2006. * Address for reprints: Han-Jung Chen, MD, PhD, Department of Neurosurgery, E-Da Hospital, I-Shou University, 1 E-Da Road, Yan-Chau Shiang, Kaohsiung 824, Taiwan. (Email: chenmd{at}ms8.hinet.net).
Objectives: Ischemic spinal cord injury is a serious complication of aortic surgery. Although the extracellular signal-regulated kinases 1 and 2 are generally regarded as related to cell proliferation and survival, increasing evidence suggests that the role of the extracellular signal-regulated kinase pathway in ischemia/reperfusion injury is much more sophisticated.
Methods: Spinal cord ischemia in rats was induced by occluding the thoracic descending aorta with a balloon catheter introduced through a femoral artery, accompanied by concomitant exsanguination. Rats in the control group were given dimethyl sulfoxide (vehicle) before undergoing spinal cord ischemia/reperfusion injury. In the U0126-treated group, rats were pretreated with a specific inhibitor of the mitogen-activated protein kinase/extracellular signal-regulated kinases 1 and 2, U0126, to inhibit extracellular signal-regulated kinases 1 and 2 phosphorylation. The sham-operated rats underwent aortic catheterization without occlusion. Parameters, including neurologic performance, neuronal survival, inflammatory cell infiltration, and interleukin-1ß production in the spinal cords, were compared between groups.
Results: Early extracellular signal-regulated kinases 1 and 2 phosphorylation was observed after injury in the control group, followed by abundant microglial accumulation in the infarct area and increased interleukin-1ß expression. In the U0126 group, U0126 treatment completely blocked extracellular signal-regulated kinases 1 and 2 phosphorylation. Microglial activation and spinal cord interleukin-1ß levels were significantly reduced. Neuronal survival and functional performance were improved.
Conclusions: The mitogen-activated protein kinase/extracellular signal-regulated kinase pathway may play a noxious role in spinal cord ischemia/reperfusion injury by participating in inflammatory reactions and cytokine production. Targeting this pathway may be of potential value in terms of therapeutic intervention.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |